Jacobio Pharmaceuticals Group Co Ltd
Jacobio Pharmaceuticals Group's GHG Emissions Data Preview
In 2023, Jacobio Pharmaceuticals Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Jacobio Pharmaceuticals Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
Verified Sources Behind Jacobio Pharmaceuticals Group’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Jacobio Pharmaceuticals Group’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Insights into Jacobio Pharmaceuticals Group's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Jacobio Pharmaceuticals Group amounted to 1,510.42 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Jacobio Pharmaceuticals Group increased by 68.77%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Jacobio Pharmaceuticals Group's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Jacobio Pharmaceuticals Group's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Jacobio Pharmaceuticals Group were 33.98 metric tons of CO₂ equivalent (tCO₂e). a
Has Jacobio Pharmaceuticals Group reduced its Scope 1 emissions over time?
Since 2021, Jacobio Pharmaceuticals Group's Scope 1 emissions have increased by 205.85%, reflecting a rising long-term trend in Scope 1 emissions over time. a
Compared to the previous year (2022), Jacobio Pharmaceuticals Group's Scope 1 emissions increased by 239.8%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
What are Jacobio Pharmaceuticals Group's Scope 2 emissions?
In 2023, Jacobio Pharmaceuticals Group reported Scope 2 greenhouse gas (GHG) emissions of 1,476.44 tCO₂e without specifying the calculation method. a
Has Jacobio Pharmaceuticals Group reduced its Scope 2 emissions over time?
Since 2021, Jacobio Pharmaceuticals Group's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 80.2%, reflecting a rising long-term trend in Scope 2 emissions over time. a
Compared to the previous year (2022), Jacobio Pharmaceuticals Group's Scope 2 emissions (Unspecified Calculation Method) rose by 66.83% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
What methodology does Jacobio Pharmaceuticals Group use for Scope 2 reporting?
In 2023, Jacobio Pharmaceuticals Group reported its Scope 2 emissions using an unspecified methodology. a
Jacobio Pharmaceuticals Group's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)